Higher Exchanges cover art

All Episodes

Higher Exchanges — 104 episodes

#
Title
1

Cannabis 3.0: The Battle for the Next Model with Scott Grossman

2

Inside the World’s Largest Cannabis ETF: How Dan Ahrens Picks Stocks

3

Inside the DEA Hearings with Christian Bax

4

Can Cannabis Grow Again? | Episode 100 with Nick Gastevich

5

DEA, Virginia & the Future of Cannabis

6

Cannabis Rescheduling Is Here. What Happens Next? | Hirsh Jain

7

Cannabis Lending After Schedule III with Steven Ernest of Chicago Atlantic

8

Is Cannabis Finally Investable Again? Rescheduling, GTI, Vireo & C21 Deep Dive

9

Finding Alpha in Cannabis: Allocation, Debt, and What Actually Works w/ Jerry Derevyanny

10

LEEF Q4 2025 Earnings Review: Inside the Transformation with CEO Micah Anderson

11

Inside the World’s Leading Cannabis Company | Curaleaf CEO Boris Jordan on Rescheduling, Capital Markets, and Consolidation

12

Is CBD Back? A Conversation with Bill Morachnick, CEO of Charlotte’s Web

13

Five Hard Questions Facing Cannabis Investors

14

TerrAscend at a Turning Point: Federal Reform, Capital Strategy, and the Path Forward

15

Cannabis Rescheduling: A Tailwind for the Cannabis 2.0 M&A Cycle

16

Cannabis Schedule III Breakdown: What It Means for Policy, Capital Markets, and Investors

17

2025 Cannabis Investing Review & 2026 Preview

18

What the Hemp Is Going On? — with Whitt Steineker

19

Q3 Earnings Review with LEEF Brands CEO Micah Anderson

20

Cannabis Done Right with Jetty CEO Ron Gershoni

21

Minnesota's New Era with Aaron Edelheit

22

The Future of Intoxicating Hemp with Tucker Johnson

23

Building Momentum with Aaron Miles, CIO of Verano

24

Elevating the Game with Jamie Medola

25

Tier One MSO Earnings – Q2 2025 Highlights

26

Know What You Own Starring Scott Grossman

27

New York is Rising Starring Jeff Schultz

28

Conquering the Universe with Ted Lidie, Founder of Alien Labs

29

The Path Forward Starring Sammy J

30

Conferences, Courts, and Cannabis Updates

31

The Unfiltered Truth with Seth Yakatan

32

The Global Playbook with Zachary George, CEO of SNDL

33

Where’s the Growth? Starring Hirsh Jain

34

How to Win in Cannabis with Mitchell Osak

35

Grow Smarter: Learning from Cannabis Failures

36

Deep Dive with Colin Ferrian: Credit Markets, Pricing Trends, and the Hemp Industry

37

Navigating the New Cannabis Landscape with Ascend’s Sam Brill

38

The Future of the Cannabis Industry with FiSai's Erich Mauf

39

Jason Wild & Ziad Ghanem Break Down TerrAscend’s 2024 Growth & Future Plans

40

Breaking Down Cannabis Earnings with CannaVestments

41

The Road Ahead: Sammy J’s Take on Cannabis Industry Recovery

42

Can Cannabis Stocks Recover? Insights from Turning Point Brands' Scott Grossman

43

How to Play the Cannabis Beverage Boom With Craig Lewis, Founder & CEO of Flyers Cocktail Co.

44

Four Fundamental Catalysts with LEEF Brands CEO, Micah Anderson

45

Signs of Recovery With Kyle Sherman, Founder and CEO of Flowhub

46

Is the MSO Model Broken Starring Jerry Derevyanny

47

2025 Cannabis Investing Predictions

48

Hemp is Living the Cannabis Dream

49

Boise Schiller Flexner Case Next Steps With Jason Wild, Emily Paxhia, Erik Luna, and Weldon Angelos

50

Adapting to Change With AYR Interim CEO Steven M. Cohen

51

Unlocking Potential With Ascend CEO Sam Brill

52

Revisiting the Thesis With Dai Truong and Doug Kass

53

2024 Election Preview Starring Hirsh Jain

54

The Sunshine State Starring Dan Neville and Brady Cobb

55

Three Benzinga Takeaways

56

Who’s Better for Cannabis: Harris or Trump?

57

Efficient Craft Cannabis With Grown Rogue CEO Obie Strickler

58

Finding Florida Opportunities With Emily Paxhia

59

Farm Bill Flower Opportunities With Kyle Kazan and Graham Farrar

60

Unpacking Political Catalysts With Jeff Schultz

61

Harvesting Adult-Use Opportunities With AYR Wellness With CEO David Goubert

62

Catching Up With CannaVestments

63

Operator Spotlight: TerrAscend With Jason Wild and Ziad Ghanem

64

Trump Tips His Hand On Cannabis Policy

65

S3 Comments Review and 2Q Earnings Preview

66

Mid-2024 State Catalyst Review With Hirsh Jain

67

Mid-2024 Federal Catalyst Review

68

Curaleaf’s Hemp-Derived THC Launch With CEO Matt Darin

69

Optimizing Assets With The Cannabist Company CEO David Hart

70

The Blame Game

71

Merger Mania

72

Reality Doesn't Bite

73

Rescheduling Reaction and Earnings Review With CannaVestments

74

Political and Earnings Updates With Cresco CEO Charlie Bachtell

75

Cash Flow Is King With Verano’s George Archos

76

The DEA Agrees With Schedule III Starring Boris Jordan and Hirsh Jain

77

Waiting on the World to Change

78

The Waiting Is the Hardest Part

79

The Catalyst Table Starring Hirsh Jain

80

Florida Update With AYR Wellness CEO David Goubert

81

Cannabis Catalyst Update With Sammy J

82

TerrAscend Q4 2023 Earnings Review with Jason Wild and Ziad Ghanem

83

Ascend Q4 2023 Earnings Review with CEO John Hartmann

84

Curaleaf Earnings Review with Boris Jordan and CannaVestments

85

GTI, Trulieve, and Verano Q4 Earnings Reviews

86

Earnings Preview and Germany Review With Boris Jordan

87

The Thesis Is in Tact Starring Sammy J

88

Do Valuations Matter?

89

The Improving Risk-Reward Equation for US Cannabis

90

Appreciating the Good Times With Verano’s Darren Weiss and Aaron Miles

91

Reviewing the HHS Recommendation With Brady Cobb and Boris Jordan

92

Returning to Growth

93

2024 Cannabis Investing Preview

94

Recapping 2023's Top Cannabis Investing Stories

95

Curaleaf Uplisting With Boris Jordan

96

Ascend Review With John Hartmann

97

What’s the Bear Case?

98

AYR Earnings Review With David Goubert

99

Verano Earnings Review With Darren Weiss and Aaron Miles

100

Analyzing the Drawdown

101

Potential New States and a Groundbreaking Lawsuit

102

TerrAscend Review With Jason Wild, Ziad Ghanem, and Keith Stauffer

103

TSX and DC Updates With Boris Jordan

104

The Origin Story